Inactive Instrument
Isracann Biosciences Inc. Stock Canadian Securities Exchange
Stocks
IPOT
CA46501D1087
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.06M 5.3M 4.89M 4.51M 8.49M 584M 8.68M 58.44M 22.99M 286M 22.77M 22.27M 984M | P/E 2021 |
-1.24x | P/E 2022 | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 5.85M 5.11M 4.72M 4.35M 8.2M 563M 8.38M 56.38M 22.18M 276M 21.97M 21.49M 950M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
99.83% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Ajay Kala
CEO | Chief Executive Officer | - | 2023-01-19 |
Yana Popova
DFI | Director of Finance/CFO | 44 | 2017-11-14 |
Bob Mehr
PRN | Corporate Officer/Principal | - | 2022-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Bromley
BRD | Director/Board Member | 36 | 2019-12-18 |
Yana Popova
BRD | Director/Board Member | 44 | 2017-11-14 |
George Vrabec
BRD | Director/Board Member | - | 2022-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 176 | ||
| -1.32% | +5.33% | -8.55% | -5.18% | 13.54B | ||
| -3.30% | +9.97% | -27.67% | -49.81% | 5.27B | ||
| -2.47% | +7.14% | +0.62% | -4.09% | 4.72B | ||
| -5.06% | +6.38% | +8.55% | -32.43% | 4.07B | ||
| -2.65% | +2.32% | +4.01% | -8.76% | 3.75B | ||
| 0.00% | +9.56% | -4.89% | -3.35% | 3.57B | ||
| -3.45% | +9.23% | -5.06% | +7.03% | 3.39B | ||
| -3.77% | +0.45% | -13.12% | -22.74% | 2.42B | ||
| -2.82% | +3.13% | -1.88% | +49.73% | 1.86B | ||
| Average | -2.48% | +2.57% | -5.33% | -7.73% | 4.73B | |
| Weighted average by Cap. | -2.43% | +3.08% | -6.55% | -10.97% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -25.16M -21.98M -20.29M -18.7M -35.24M -2.42B -36.02M -242M -95.37M -1.19B -94.47M -92.4M -4.08B | -4.69M -4.1M -3.78M -3.49M -6.57M -452M -6.72M -45.23M -17.79M -221M -17.62M -17.24M -762M |
| Net Debt | -1.96M -1.71M -1.58M -1.46M -2.74M -189M -2.8M -18.88M -7.42M -92.37M -7.35M -7.19M -318M | -214K -187K -173K -159K -300K -20.6M -306K -2.06M -811K -10.09M -803K -786K -34.74M |
Employees
-
Sector
Pharmaceuticals
















